Medical Instruments & Supplies · Healthcare
CFO, Chief Accounting Officer
2024-09-03–present
CFO
Sysco Corp (SYY)Chief Accounting Officer
Baxter International Inc (BAX)Equibles does not estimate personal net worth.
Get an email with a short summary when Sysco Corp publishes a filing, an earnings call transcript or a press release.
Get SYY alertsJoel Grade is recorded as CFO at Sysco Corp (SYY), Chief Accounting Officer at Baxter International Inc (BAX) since September 3, 2024 and CFO at Baxter International Inc (BAX). The newest filing on record that lists Joel Grade as CFO at Baxter International Inc (BAX) is dated March 23, 2026. Baxter International Inc reported in an 8-K filed September 3, 2024 that Joel Grade was appointed Interim Chief Accounting Officer, effective September 3, 2024. The proxy statement of Baxter International Inc reports total compensation of $8,209,568 for Joel Grade in fiscal 2025, including a base salary of $827,825. Disclosed compensation is on record for 3 fiscal years. Joel Grade has spoken on 13 earnings calls and 1 other investor event across 2 companies, most recently for Baxter International Inc on March 11, 2026. Those appearances were for Baxter International Inc (BAX) and Sysco Corp (SYY). Baxter International Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Sysco Corp is classified in the Food Distribution industry within the Consumer Defensive sector. Other leadership on record at Baxter International Inc includes Andrew Hider (CEO, CFO and Board Member), Brent Shafer (CEO and Chairman), José Almeida (CEO) and 7 others.
“On September 3, 2024, the Board of Directors of the Company approved the appointment of Mr. Joel Grade, the Company's Executive Vice President and Chief Financial Officer, as the Company's Chief Accounting Officer and PAO on an interim basis, effective September 3, 2024, while continuing to serve in his current position.”
“And again, thanks for your interest in Baxter. Yeah, I'd call it a sub two. So we do have some business there, but, again, it's small.”
“Fourth quarter, 2025 global sales from continuing operations totaled $3 billion and increased 8% on a reported basis and 3% on an operational basis. Performance in the quarter reflects growth.”
“Let me also take a moment to welcome Kevin Moran as our new Vice President of Investor Many of you already know Kevin from his prior studies in the space. Kevin brings valuable finance, IR, and importantly, health care.”
“I'll start my remarks today with some additional commentary regarding the P&L profile. Turning to our updated outlook for the second quarter adjusted gross margins from continuing operations for 40.7%, a decrease of 170 basis points compared to the prior yield.”
“I'll take the first part, and then I'll pass it over to Heather for the second.”
2024-09-03–present
Start not stated–present
Last confirmed March 23, 2026
Medical Instruments & Supplies · Healthcare
CFO, Chief Accounting Officer
2024-09-03–present
SYY
Food Distribution · Consumer Defensive
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Baxter International Inc (BAX) | Former Executive Vice President and CFO | $827,825 | $8,209,568 |
| 2024 | Baxter International Inc (BAX) | Executive Vice President and Chief Financial Officer | $810,000 | $6,507,548 |
| 2023 | Baxter International Inc (BAX) | Executive Vice President and Chief Financial Officer | $164,384 | $4,876,222 |